BackImmage Biotherapeutics Overview

Immage Biotherapeutics Current Assets

Immage Biotherapeutics's current assets is $57K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$57020.00
↓ 82.60% YoYΔ $-270750.00 vs prior year quarter

Peer trimmed avg / median

Loading

Immage Biotherapeutics Current Assets History

Loading

Immage Biotherapeutics vs. peers: Current Assets Comparison

Loading

Immage Biotherapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Immage Biotherapeutics (IMMG) FAQ

Immage Biotherapeutics's current assets stands at $57K as of February 2017. That compares with $330K in the prior-year period — down 82.6% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Immage Biotherapeutics reported $57K in current assets versus $330K a year earlier — a 82.6% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $330K in the prior-year period — down 82.6% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Immage Biotherapeutics's current assets evolved across reporting periods, while the comparison chart places IMMG next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Questions & Answers